Get the Stockscreener App
0.6006
2.18%
-0.0134
After Hours:
.60
-0.0006
-0.10%
Inspira Technologies Oxy B H N Ltd stock is traded at $0.6006, with a volume of 176.03K.
It is down -2.18% in the last 24 hours and down -7.60% over the past month.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
See More
Previous Close:
$0.614
Open:
$0.639
24h Volume:
176.03K
Relative Volume:
0.32
Market Cap:
$25.99M
Revenue:
-
Net Income/Loss:
$-11.05M
P/E Ratio:
-1.001
EPS:
-0.6
Net Cash Flow:
$-9.54M
1W Performance:
+1.93%
1M Performance:
-7.60%
6M Performance:
-50.36%
1Y Performance:
-30.96%
1-Day Range:
$0.5914
$0.64
1-Week Range:
$0.5646
$0.64
52-Week Range:
$0.4026
$1.65
Inspira Technologies Oxy B H N Ltd Stock (IINN) Company Profile
Name
Inspira Technologies Oxy B H N Ltd
Sector
Industry
Phone
-
Address
-
Compare IINN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IINN
Inspira Technologies Oxy B H N Ltd
|
0.6006 | 26.57M | 0 | -11.05M | -9.54M | -0.60 |
|
ABT
Abbott Laboratories
|
111.04 | 196.53B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
370.50 | 146.14B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
93.01 | 122.74B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.99 | 107.15B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
83.89 | 49.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Inspira Technologies Oxy B H N Ltd Stock (IINN) Latest News
Published on: 2026-03-05 17:35:58 - baoquankhu1.vn
Inspira Technologies Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement - 富途牛牛
Inspira’s Medtech Pitch Rides On FDA Clearance And Hospital Uptake - Finimize
Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors - Intellectia AI
Inspira Receives Nasdaq Notification Regarding Minimum Market Value Deficiency - 富途牛牛
IINN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Smart Money: Is Inspira Technologies Oxy BHN Ltd Equity Warrant trading at a discountBear Alert & Stepwise Trade Execution Plans - baoquankhu1.vn
Inspira™ Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA™ ART100 Functionality and Performance in Clinical Scenarios - Intellectia AI
Inspira Technologies Amends Bio-View Debenture and Faces Nasdaq Market Value Deficiency Notice - TipRanks
Inspira Technologies Receives Nasdaq Notice of Non-Compliance with Market Value Requirement - Quiver Quantitative
Nasdaq alerts Inspira (NASDAQ: IINN) on $35,000,000 value gap - Stock Titan
Inspira Technologies Oxy B.H.N. Ltd.Warrant (NQ: IINNW - The Chronicle-Journal
IINN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital - Intellectia AI
Published on: 2026-02-22 00:08:41 - baoquankhu1.vn
Inspira Technologies Oxy B.H.N. Ltd. Deploys ART100 at A New Premier New York Academic Medical Center - marketscreener.com
Inspira Technologies Deploys ART100 at Top-Ranked New York Academic Medical Center - TipRanks
Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State - The Manila Times
Inspira Technologies Sets Up $2 Million At-the-Market Equity Program with A.G.P. - TipRanks
Inspira Technologies (NASDAQ: IINN) launches $2,015,985 ATM share program - Stock Titan
IINN Should I Buy - Intellectia AI
Inspira Technologies to Showcase FDA-Cleared INSPIRA™ ART100 System at AmSECT 2026 Conference - Quiver Quantitative
Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks - The Manila Times
Market Fear: Is OVLY benefiting from interest rate changes2025 Risk Factors & Accurate Technical Buy Alerts - baoquankhu1.vn
Published on: 2026-02-16 19:32:24 - mfd.ru
Gap Down: Will Inspira Technologies Oxy BHN Ltd Equity Warrant announce a stock splitJuly 2025 Movers & Weekly High Return Forecasts - baoquankhu1.vn
Is Inspira Technologies Oxy B.H.N. Ltd. exposed to currency risksJuly 2025 WrapUp & High Accuracy Swing Trade Signals - mfd.ru
Market Pulse: Is VCICU a speculative investmentFed Meeting & Daily Chart Pattern Signals - baoquankhu1.vn
Inspira Technologies Faces Nasdaq Minimum Bid Price Deficiency, Retains Listing Through Compliance Window - TipRanks
Inspira stock stays below $1 for 30 days, triggering Nasdaq notice - Stock Titan
Why is Inspira Technologies Oxy B.H.N. Ltd. Equity Warrant stock going upJuly 2025 Rallies & Capital Protection Trading Alerts - mfd.ru
What is the long term forecast for Inspira Technologies Oxy B.H.N. Ltd. Equity Warrant stockExit Point & Breakout Confirmation Trade Signals - mfd.ru
Published on: 2026-02-11 17:41:32 - mfd.ru
Bearish Setup: What is the implied volatility of TherapeuticsMD IncPortfolio Risk Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
Why Inspira Technologies Oxy B.H.N. Ltd. stock appeals to analystsEarnings Recap Summary & Free Technical Pattern Based Buy Signals - mfd.ru
Inspira Announces Pricing of $4.75 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules - 富途牛牛
Inspira Technologies Secures Major Procurement Approval - Intellectia AI
Inspira Secures Vendor Approval from $12 Billion Revenue HMO (World’s 2nd Largest), Enabling Immediate ART100 Deployment - The Manila Times
Inspira secures vendor approval from $12 billion revenue HMO (world's 2nd largest), enabling immediate ART100 deployment - marketscreener.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Inspira Technologies Wins Clalit HMO Vendor Status, Clearing Path for ART100 Rollout - TipRanks
Clalit vendor greenlight lets Inspira (NASDAQ: IINN) deploy ART100 across major HMO - Stock Titan
Inspira Technologies (NASDAQ: IINN) prices $4.75M share and warrant offering - Stock Titan
Inspira Announces Pricing of $4.75 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules - The Manila Times
Inspira to raise $4.75M, add warrants in deal with healthcare investor - Stock Titan
Market Fear: Is Inspira Technologies Oxy B.H.N. Ltd. stock heavily shortedJuly 2025 Volume & Low Volatility Stock Recommendations - baoquankhu1.vn
Inspira Technologies OXY B.H.N. Ltd. Validates Next-Gen Standalone HYLA Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market - marketscreener.com
Inspira Technologies announces validation of advanced blood labs of HYLA - TipRanks
Inspira Technologies Validates Standalone HYLA Blood Sensor, Targeting $50 Billion Heart-Lung Surgery Market - TipRanks
Inspira Technologies Announces Successful Validation of Next-Generation Standalone HYLA™ System for Enhanced Patient Monitoring in Heart-Lung Surgery - Quiver Quantitative
Inspira Technologies Validates Next-Gen Standalone HYLA™ Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market - Yahoo Finance
Inspira Technologies Oxy B H N Ltd Stock (IINN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):